Clovis Oncology Inc (NASDAQ:CLVS)

3.15
Delayed Data
As of Nov 30
 +0.06 / +1.94%
Today’s Change
3.02
Today|||52-Week Range
11.10
-34.37%
Year-to-Date
No recent news for Clovis Oncology Inc.

Today’s Trading

Previous close3.09
Today’s open3.08
Day’s range3.03 - 3.18
Volume320,461
Average volume (3 months)3,032,733
Market cap$419.2M
Data as of 4:04pm ET, 11/30/2021

Growth & Valuation

Earnings growth (last year)+41.08%
Earnings growth (this year)+47.40%
Earnings growth (next 5 years)+86.83%
Revenue growth (last year)+15.05%
P/E ratioNM
Price/Sales2.46
Price/Book--

Competitors

----
MIRMMirum Pharmaceutical...+1.27+9.73%
MRNSMarinus Pharmaceutic...+0.10+0.86%
IPHAInnate Pharma SA-0.01-0.20%
Data as of 4:00pm ET, 11/30/2021

Financials

Next reporting dateFebruary 23, 2022
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$164.5M
Annual profit (last year)-$369.2M
Net profit margin-224.41%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boulder, Colorado

Forecasts